Page 5 - New Treatment Options for Adults and Children with Overactive Bladder
P. 5
Disclosure of Financial Support
o This program has received financial support from
Duchesnay in the form of an educational grant.
o Potential for conflict(s) of interest:
o Duchesnay benefits from the sale of a product
which will be discussed in this program:
Propiverine (Mictoryl)
